Equities

Biora Therapeutics Inc

Biora Therapeutics Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)2.54
  • Today's Change-0.10 / -3.79%
  • Shares traded65.00k
  • 1 Year change-83.92%
  • Beta1.2004
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Biora Therapeutics, Inc. is a biotechnology company, which is focused on creating smart pills designed for targeted drug delivery to the gastrointestinal (GI) tract, and systemic, needle-free delivery of biotherapeutics. The Company’s pipeline includes two therapeutic delivery platforms: NaviCap and BioJet. The NaviCap, targeted oral delivery platform, which is designed to improve outcomes for patients with inflammatory bowel disease through treatment at the site of disease in the gastrointestinal tract. The BioJet, systemic oral delivery platform, which is designed to replace injection for better management of chronic diseases through needle-free, oral delivery of large molecules. It has two demonstration drug-device combination programs for the BioJet platform, BT-200 (GLP-1 receptor agonist) and BT-002 (adalimumab variant). Its other two programs include BT-600 (NaviCap + tofacitinib) and BT-001 (NaviCap + variant of adalimumab) for the treatment of ulcerative colitis.

  • Revenue in USD (TTM)860.00k
  • Net income in USD-86.81m
  • Incorporated2012
  • Employees58.00
  • Location
    Biora Therapeutics Inc4330 La Jolla Village Drive, Suite 200SAN DIEGO 92122United StatesUSA
  • Phone+1 (760) 494-1555
  • Fax+1 (248) 848-1623
  • Websitehttps://www.bioratherapeutics.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Vincerx Pharma Inc0.00-28.90m9.71m42.00--0.6287-----1.31-1.310.000.52060.00----0.00-101.76---136.61--------------0.00------36.24------
Viaderma Inc17.80m2.31m9.87m75.000.00050.000031.820.554516.8416.84129.62255.590.412624.691.21237,331.305.36--6.53--28.90--12.99--2.075.660.1718---29.15---40.70------
CERo Therapeutics Holdings Inc0.00-2.54m10.33m8.00---------0.3796-0.37960.00-0.92260.00----0.00-9.96---33.80-----------------------279.82------
Yubo International Biotech Ltd454.29k-1.42m10.40m18.00------22.89-0.0118-0.01180.0038-0.02110.24620.59863.4925,238.33-82.33------80.30---334.36--0.1707-4,795.69----479.86--0.8224------
Kiora Pharmaceuticals Inc16.02m2.67m10.47m12.00--0.31633.880.6536-7.76-7.766.6111.140.5279--7.161,335,000.0010.54-70.5211.20-81.86----19.98-2,040.61----0.00------3.97------
Dominari Holdings Inc9.51m-22.02m10.49m26.00--0.2463--1.10-3.85-3.851.676.780.1629--2.60365,730.80-37.71-26.82-39.96-27.45-----231.55-3,353.52---5.050.00----135.7512.72--63.99--
Ensysce Biosciences Inc1.44m-11.28m10.89m7.00--3.29--7.57-2.98-2.980.28450.22180.3142--8.67205,418.60-246.46-17.68-376.98-19.42-----784.43-715.78---5.930.235---11.61--57.64------
Conduit Pharmaceuticals Inc0.00-5.17m10.93m7.00---------0.0667-0.06670.00-0.07380.00----0.00-312.39-----------------21.32--------89.05------
Biora Therapeutics Inc860.00k-86.81m11.02m58.00------12.82-55.72-55.630.2398-24.850.0253--1.0514,827.59-255.56-122.84---369.01-----10,094.19-415.10---------98.69-87.44-154.63---53.68--
BioRestorative Therapies Inc174.10k-8.00m11.14m11.00--1.03--63.99-1.22-1.220.0291.560.0118--6.6515,827.27-54.42-192.11-68.75-329.3247.45---4,597.79-19,116.15----0.00--21.705.6143.67--67.77--
Cingulate Inc0.00-19.10m11.15m13.00--0.8786-----141.60-141.600.003.950.00----0.00-368.85-----------------47.380.0042-------33.14------
Nascent Biotech Inc0.00-1.92m11.45m-----------0.012-0.0120.00-0.0030.00-------1,256.81-708.50-----------589.83------------25.47------
Imunon Inc0.00-18.08m11.52m33.00--2.01-----1.92-1.920.000.3980.00----0.00-94.15-50.18-132.90-60.27-------5,725.88----0.00---100.00--45.64--26.69--
Cardio Diagnostics Holdings Inc39.14k-8.77m12.03m7.00--2.98--307.42-0.4899-0.48990.00210.13190.0073--9.135,591.43-163.16---268.73-------22,414.13-----9.320.0295--1,696.84---79.72------
Indaptus Therapeutics Inc0.00-15.75m12.13m7.00--1.65-----1.86-1.860.000.72090.00----0.00-108.73-66.55-126.30-81.23------------0.00-------7.68------
Data as of Nov 08 2024. Currency figures normalised to Biora Therapeutics Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.